99-24726. National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting  

  • [Federal Register Volume 64, Number 184 (Thursday, September 23, 1999)]
    [Notices]
    [Page 51551]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-24726]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    National Institute of Allergy and Infectious Diseases; Notice of 
    Closed Meeting
    
        Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
    amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
    meeting.
        The meeting will be closed to the public in accordance with the 
    provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
    U.S.C., as amended. The contract proposals and the discussions could 
    disclose confidential trade secrets or commercial property such as 
    patentable material, and personal information concerning individuals 
    associated with the contract proposals, the disclosure of which would 
    constitute a clearly unwarranted invasion of personal privacy.
    
        Name of Committee: National Institutes of Allergy and Infectious 
    Diseases Special Emphasis Panel Analytical Chemistry Evaluation.
        Date: October 7, 1999
        Time: 8:30 a.m. to 5:00 p.m.
        Agenda: To review and evaluate contract proposals.
        Place: Holiday Inn Bethesda, Connecticut Room, 8120 Wisconsin 
    Avenue, Bethesda, MD 20892-7610.
        Contact Person: Vassil S. Georgiev, PHD, Scientific Review 
    Administrator, Scientific Review Program, Division of Extramural 
    Activities, NIAID, NIH, Room 2217, 6700-B Rockledge Drive, MSC, 
    7610, Bethesda, MD 20892-7610, 301-496-2550.
    
    (Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
    Allergy, Immunology, and Transplantation Research; 93.856, 
    Microbiology, and Infectious Diseases Research, National Institutes 
    of Health, HHS)
    
        Dated: September 15, 1999.
    LaVerne Y. Stringfield,
    Director, Office of Federal Advisory Committee Policy, NIH.
    [FR Doc. 99-24726 Filed 9-22-99; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Effective Date:
10/7/1999
Published:
09/23/1999
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
99-24726
Dates:
October 7, 1999
Pages:
51551-51551 (1 pages)
PDF File:
99-24726.pdf